Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo-Reference-Cited by-同舟云学术

Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo

Published:2017-05 Issue:5 Volume:187 Page:501-512
ISSN:0033-7587
Container-title:Radiation Research
language:en
Short-container-title:Radiation Research

Author:

Morel Katherine L.¹,Ormsby Rebecca J.¹,Bezak Eva²,Sweeney Christopher J.³,Sykes Pamela J.¹

Affiliation:

1. Molecular Medicine and Pathology, Flinders Centre for Innovation in Cancer, Flinders University and Medical Centre, Bedford Park, Adelaide, South Australia

2. Medical Radiation, School of Health Sciences, University of South Australia, Adelaide, South Australia

3. Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts

Publisher

Radiation Research Society

Subject

Radiology Nuclear Medicine and imaging,Radiation,Biophysics

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What's Changed in 75 Years of RadRes? – An Australian Perspective on Selected Topics;Radiation Research;2024-07-05

2. In silico exploration of anti-prostate cancer compounds from differential expressed genes;BMC Urology;2024-07-03

3. Azido derivatives of sesquiterpene lactones: Synthesis, anticancer proliferation, and chemistry of nitrogen-centered radicals;Results in Chemistry;2024-07

4. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway;Cancer Chemotherapy and Pharmacology;2023-12-23

5. ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway;Biomedicine & Pharmacotherapy;2023-07